-
Je něco špatně v tomto záznamu ?
Evaluating the need for standardised disease manifestation categories in patients infected with the tick-borne encephalitis virus: A Delphi panel
K. Halsby, G. Dobler, A. Easton, G. Karelis, L. Krbková, J. Kyncl, J. Sellner, F. Strle, M. Veje, J. Zajkowska, D. Zavadska, FJ. Angulo, A. Pilz, W. Erber, M. Gabriel, J. Russo, M. Price, H. Madhava, UK. Meyding-Lamadé
Jazyk angličtina Země Nizozemsko
Typ dokumentu časopisecké články
- MeSH
- delfská metoda * MeSH
- klíšťová encefalitida * epidemiologie virologie diagnóza MeSH
- konsensus MeSH
- lidé MeSH
- viry klíšťové encefalitidy * klasifikace MeSH
- Check Tag
- lidé MeSH
- Publikační typ
- časopisecké články MeSH
Categorization systems for tick-borne encephalitis virus (TBEV) infection lack consistency in classifying disease severity. To evaluate the need for a standard, consensus-based categorisation system for TBEV infection across subtypes, we gathered an expert panel of clinicians and scientists with diverse expertise in TBEV infection. Consensus was sought using the Delphi technique, which consisted of 2 web-based survey questionnaires and a final, virtual, consensus-building exercise. Ten panellists representing 8 European countries participated in the Delphi exercise, with specialities in neurology, infectious disease, paediatrics, immunology, virology, and epidemiology. Panellists reached unanimous consensus on the need for a standardised, international categorisation system to capture both clinical presentation and severity of TBEV infection. Ideally, such a system should be feasible for use at bedside, be clear and easy to understand, and capture both the acute and follow-up phases of TBEV infection. Areas requiring further discussion were (1) the timepoints at which assessments should be made and (2) whether there should be a separate system for children. This Delphi panel study found that a critical gap persists in the absence of a feasible and practical classification system for TBEV infection. Specifically, the findings of our Delphi exercise highlight the need for the development of a user-friendly classification system that captures the acute and follow-up (i.e., outcome) phases of TBEV infection and optimally reflects both clinical presentation and severity. Development of a clinical categorisation system will enhance patient care and foster comparability among studies, thereby supporting treatment development, refining vaccine strategies, and fortifying public health surveillance.
Bundeswehr Institute of Microbiology Munich Germany
Department of Infectious Diseases and Tropical Medicine University Munich Germany
Encephalitis International North Yorkshire United Kingdom
Krankenhaus Nordwest Frankfurt Germany
Rīga East University Hospital Hipokrata St 2 Rīga LV 1079 Latvia
Rīga Stradiņš University Dzirciema St 16 Rīga LV 1007 Latvia
RTI Health Solutions 3040 East Cornwallis Road Research Triangle Park NC United States
Vaccines and Antivirals Medical Affairs Pfizer Corporation Austria Vienna Austria
Vaccines and Antivirals Medical Affairs Pfizer Ltd Surrey United Kingdom
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc25010431
- 003
- CZ-PrNML
- 005
- 20250429135145.0
- 007
- ta
- 008
- 250415s2025 ne f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1016/j.ttbdis.2024.102431 $2 doi
- 035 __
- $a (PubMed)39708718
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a ne
- 100 1_
- $a Halsby, Kate $u Vaccines and Antivirals Medical Affairs, Pfizer Ltd, Surrey, United Kingdom. Electronic address: kate.halsby@pfizer.com
- 245 10
- $a Evaluating the need for standardised disease manifestation categories in patients infected with the tick-borne encephalitis virus: A Delphi panel / $c K. Halsby, G. Dobler, A. Easton, G. Karelis, L. Krbková, J. Kyncl, J. Sellner, F. Strle, M. Veje, J. Zajkowska, D. Zavadska, FJ. Angulo, A. Pilz, W. Erber, M. Gabriel, J. Russo, M. Price, H. Madhava, UK. Meyding-Lamadé
- 520 9_
- $a Categorization systems for tick-borne encephalitis virus (TBEV) infection lack consistency in classifying disease severity. To evaluate the need for a standard, consensus-based categorisation system for TBEV infection across subtypes, we gathered an expert panel of clinicians and scientists with diverse expertise in TBEV infection. Consensus was sought using the Delphi technique, which consisted of 2 web-based survey questionnaires and a final, virtual, consensus-building exercise. Ten panellists representing 8 European countries participated in the Delphi exercise, with specialities in neurology, infectious disease, paediatrics, immunology, virology, and epidemiology. Panellists reached unanimous consensus on the need for a standardised, international categorisation system to capture both clinical presentation and severity of TBEV infection. Ideally, such a system should be feasible for use at bedside, be clear and easy to understand, and capture both the acute and follow-up phases of TBEV infection. Areas requiring further discussion were (1) the timepoints at which assessments should be made and (2) whether there should be a separate system for children. This Delphi panel study found that a critical gap persists in the absence of a feasible and practical classification system for TBEV infection. Specifically, the findings of our Delphi exercise highlight the need for the development of a user-friendly classification system that captures the acute and follow-up (i.e., outcome) phases of TBEV infection and optimally reflects both clinical presentation and severity. Development of a clinical categorisation system will enhance patient care and foster comparability among studies, thereby supporting treatment development, refining vaccine strategies, and fortifying public health surveillance.
- 650 12
- $a klíšťová encefalitida $x epidemiologie $x virologie $x diagnóza $7 D004675
- 650 12
- $a delfská metoda $7 D003697
- 650 12
- $a viry klíšťové encefalitidy $x klasifikace $7 D004669
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a konsensus $7 D032921
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Dobler, Gerhard $u Bundeswehr Institute of Microbiology, Munich, Germany; Department of Infectious Diseases and Tropical Medicine, University Munich, Germany
- 700 1_
- $a Easton, Ava $u Encephalitis International, North Yorkshire, United Kingdom; Institute of Infection, Veterinary and Ecological Science, University of Liverpool, NIHR HPRU for Emerging and Zoonotic Infection, Liverpool, United Kingdom
- 700 1_
- $a Karelis, Guntis $u Rīga Stradiņš University, Dzirciema St. 16, Rīga, LV-1007, Latvia; Rīga East University Hospital, Hipokrata St. 2, Rīga, LV-1079, Latvia
- 700 1_
- $a Krbková, Lenka $u Department of Pediatric Infectious Diseases, Faculty of Medicine, Masaryk University and Faculty Hospital, Brno, Czech Republic
- 700 1_
- $a Kyncl, Jan $u Department of Infectious Diseases Epidemiology, National Institute of Public Health, Srobarova 49, Prague, Czech Republic; Department of Epidemiology and Biostatistics, Third Faculty of Medicine, Charles University, Ruska 87, Prague, Czech Republic
- 700 1_
- $a Sellner, Johann $u Department of Neurology, Landesklinikum Mistelbach-Gänserndorf, Mistelbach, Affiliated with Karl Landsteiner University of Health Sciences, Krems, Austria
- 700 1_
- $a Strle, Franc $u Department of Infectious Diseases, University Medical Centre Ljubljana, Japljeva 2, 1525 Ljubljana, Slovenia
- 700 1_
- $a Veje, Malin $u Department of Infectious Diseases, Institute of Biomedicine, Sahlgrenska Academy at Gothenburg University, Guldhedsgatan 10, 41346, Gothenburg, Sweden
- 700 1_
- $a Zajkowska, Joanna $u Department of Infectious Diseases and Neuroinfections, Medical University of Bialystok, Żurawia 14, Białystok 15-540, Poland
- 700 1_
- $a Zavadska, Dace $u Riga Stradins University, Department of Paediatrics, Children Clinical University Hospital, Riga, Vienibas gatve 45, Riga, LV1004, Latvia
- 700 1_
- $a Angulo, Frederick J $u Vaccines and Antivirals Medical Affairs, Pfizer Biopharma Group, 500 Arcola Rd, Collegeville, PA,19426, United States
- 700 1_
- $a Pilz, Andreas $u Vaccines and Antivirals Medical Affairs, Pfizer Corporation Austria, Vienna, Austria
- 700 1_
- $a Erber, Wilhelm $u Vaccines and Antivirals Medical Affairs, Pfizer Corporation Austria, Vienna, Austria
- 700 1_
- $a Gabriel, Meghan $u RTI Health Solutions, 3040 East Cornwallis Road, Research Triangle Park, NC, United States
- 700 1_
- $a Russo, Jon $u RTI Health Solutions, 3040 East Cornwallis Road, Research Triangle Park, NC, United States
- 700 1_
- $a Price, Mark $u RTI Health Solutions, 3040 East Cornwallis Road, Research Triangle Park, NC, United States
- 700 1_
- $a Madhava, Harish $u Vaccines and Antivirals Medical Affairs, Pfizer Ltd, Surrey, United Kingdom
- 700 1_
- $a Meyding-Lamadé, Uta Katharina $u Krankenhaus Nordwest, Frankfurt, Germany
- 773 0_
- $w MED00167597 $t Ticks and tick-borne diseases $x 1877-9603 $g Roč. 16, č. 1 (2025), s. 102431
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/39708718 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y - $z 0
- 990 __
- $a 20250415 $b ABA008
- 991 __
- $a 20250429135141 $b ABA008
- 999 __
- $a ok $b bmc $g 2311656 $s 1247512
- BAS __
- $a 3
- BAS __
- $a PreBMC-MEDLINE
- BMC __
- $a 2025 $b 16 $c 1 $d 102431 $e 20241220 $i 1877-9603 $m Ticks and tick-borne diseases $n Ticks Tick Borne Dis $x MED00167597
- LZP __
- $a Pubmed-20250415
